APO Research
Talk to an analyst

APO RESEARCH · REPORT

Etodolac

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Etodolac Industry Growth and Trends Forecast to 2032

23 December 2025100 pages

Choose your research edition.

Industry ResearchEtodolac Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Etodolac Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Etodolac Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Etodolac Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Etodolac Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Etodolac market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Etodolac is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Etodolac is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Etodolac is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Etodolac include Teva, Taro Pharmaceuticals, Physicians Total Care, PD-Rx Pharmaceuticals, Nucare Pharmaceuticals, Genpharm Ulc, Eon Labs, Blenheim Pharmacal and Apotex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Etodolac market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Etodolac market size, estimates, and forecasts are presented in terms of sales volume (k pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Etodolac market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Etodolac.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Etodolac market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Etodolac Market by Company

Teva

Taro Pharmaceuticals

Physicians Total Care

PD-Rx Pharmaceuticals

Nucare Pharmaceuticals

Genpharm Ulc

Eon Labs

Blenheim Pharmacal

Apotex

Amneal Pharmaceuticals

Actavis Elizabeth

Etodolac Segment by Type

Tablets

Capsules

Etodolac Segment by Application

Mild to Moderate Pain

Rheumatoid Arthritis

Osteoarthritis

Others

Etodolac Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Etodolac market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Etodolac and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Etodolac.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Etodolac manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Etodolac in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tablets Table 2. Major Company of Capsules Table 3. Global Etodolac Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Etodolac Sales by Type (2021-2026) & (k pcs) Table 5. Global Etodolac Sales Market Share in Volume by Type (2021-2026) Table 6. Global Etodolac Sales by Type (2021-2026) & (US$ Million) Table 7. Global Etodolac Sales Market Share in Value by Type (2021-2026) Table 8. Global Etodolac Price by Type (2021-2026) & (US$/pcs) Table 9. Global Etodolac Sales by Type (2027-2032) & (k pcs) Table 10. Global Etodolac Sales Market Share in Volume by Type (2027-2032) Table 11. Global Etodolac Sales by Type (2027-2032) & (US$ Million) Table 12. Global Etodolac Sales Market Share in Value by Type (2027-2032) Table 13. Global Etodolac Price by Type (2027-2032) & (US$/pcs) Table 14. North America Etodolac Sales by Type (2021-2026) & (k pcs) Table 15. North America Etodolac Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Etodolac Sales by Type (2021-2026) & (k pcs) Table 17. Europe Etodolac Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Etodolac Sales by Type (2021-2026) & (k pcs) Table 19. Asia-Pacific Etodolac Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Etodolac Sales by Type (2021-2026) & (k pcs) Table 21. Latin America Etodolac Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Etodolac Sales by Type (2021-2026) & (k pcs) Table 23. Middle East and Africa Etodolac Sales by Type (2021-2026) & (US$ Million) Table 24. Etodolac Industry Trends Table 25. Etodolac Industry Drivers Table 26. Etodolac Industry Opportunities and Challenges Table 27. Etodolac Industry Restraints Table 28. Global Etodolac Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Etodolac Revenue Market Share by Company (2021-2026) Table 30. Global Etodolac Sales by Company (2021-2026) & (k pcs) Table 31. Global Etodolac Sales Share by Company (2021-2026) Table 32. Global Etodolac Market Price by Company (2021-2026) & (US$/pcs) Table 33. Global Etodolac Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Etodolac Major Company Production Sites and Headquarters Table 35. Global Etodolac Company, Product Type & Application Table 36. Global Etodolac Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Etodolac by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Etodolac Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Etodolac Sales by Region (2021-2026) & (k pcs) Table 41. Global Etodolac Sales Market Share in Volume by Region (2021-2026) Table 42. Global Etodolac Sales by Region (2021-2026) & (US$ Million) Table 43. Global Etodolac Sales Market Share in Value by Region (2021-2026) Table 44. Global Etodolac Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 45. Global Etodolac Sales by Region (2027-2032) & (k pcs) Table 46. Global Etodolac Sales Market Share in Volume by Region (2027-2032) Table 47. Global Etodolac Sales by Region (2027-2032) & (US$ Million) Table 48. Global Etodolac Sales Market Share in Value by Region (2027-2032) Table 49. Global Etodolac Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2027-2032) Table 50. Global Etodolac Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Etodolac Sales by Application (2021-2026) & (k pcs) Table 52. Global Etodolac Sales Market Share in Volume by Application (2021-2026) Table 53. Global Etodolac Sales by Application (2021-2026) & (US$ Million) Table 54. Global Etodolac Sales Market Share in Value by Application (2021-2026) Table 55. Global Etodolac Price by Application (2021-2026) & (US$/pcs) Table 56. Global Etodolac Sales by Application (2027-2032) & (k pcs) Table 57. Global Etodolac Sales Market Share in Volume by Application (2027-2032) Table 58. Global Etodolac Sales by Application (2027-2032) & (US$ Million) Table 59. Global Etodolac Sales Market Share in Value by Application (2027-2032) Table 60. Global Etodolac Price by Application (2027-2032) & (US$/pcs) Table 61. North America Etodolac Sales by Application (2021-2026) & (k pcs) Table 62. North America Etodolac Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Etodolac Sales by Application (2021-2026) & (k pcs) Table 64. Europe Etodolac Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Etodolac Sales by Application (2021-2026) & (k pcs) Table 66. Asia-Pacific Etodolac Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Etodolac Sales by Application (2021-2026) & (k pcs) Table 68. Latin America Etodolac Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Etodolac Sales by Application (2021-2026) & (k pcs) Table 70. Middle East and Africa Etodolac Sales by Application (2021-2026) & (US$ Million) Table 71. Teva Company Information Table 72. Teva Business Overview Table 73. Teva Etodolac Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 74. Teva Etodolac Product Portfolio Table 75. Teva Recent Development Table 76. Taro Pharmaceuticals Company Information Table 77. Taro Pharmaceuticals Business Overview Table 78. Taro Pharmaceuticals Etodolac Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 79. Taro Pharmaceuticals Etodolac Product Portfolio Table 80. Taro Pharmaceuticals Recent Development Table 81. Physicians Total Care Company Information Table 82. Physicians Total Care Business Overview Table 83. Physicians Total Care Etodolac Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 84. Physicians Total Care Etodolac Product Portfolio Table 85. Physicians Total Care Recent Development Table 86. PD-Rx Pharmaceuticals Company Information Table 87. PD-Rx Pharmaceuticals Business Overview Table 88. PD-Rx Pharmaceuticals Etodolac Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 89. PD-Rx Pharmaceuticals Etodolac Product Portfolio Table 90. PD-Rx Pharmaceuticals Recent Development Table 91. Nucare Pharmaceuticals Company Information Table 92. Nucare Pharmaceuticals Business Overview Table 93. Nucare Pharmaceuticals Etodolac Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 94. Nucare Pharmaceuticals Etodolac Product Portfolio Table 95. Nucare Pharmaceuticals Recent Development Table 96. Genpharm Ulc Company Information Table 97. Genpharm Ulc Business Overview Table 98. Genpharm Ulc Etodolac Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 99. Genpharm Ulc Etodolac Product Portfolio Table 100. Genpharm Ulc Recent Development Table 101. Eon Labs Company Information Table 102. Eon Labs Business Overview Table 103. Eon Labs Etodolac Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 104. Eon Labs Etodolac Product Portfolio Table 105. Eon Labs Recent Development Table 106. Blenheim Pharmacal Company Information Table 107. Blenheim Pharmacal Business Overview Table 108. Blenheim Pharmacal Etodolac Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 109. Blenheim Pharmacal Etodolac Product Portfolio Table 110. Blenheim Pharmacal Recent Development Table 111. Apotex Company Information Table 112. Apotex Business Overview Table 113. Apotex Etodolac Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 114. Apotex Etodolac Product Portfolio Table 115. Apotex Recent Development Table 116. Amneal Pharmaceuticals Company Information Table 117. Amneal Pharmaceuticals Business Overview Table 118. Amneal Pharmaceuticals Etodolac Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 119. Amneal Pharmaceuticals Etodolac Product Portfolio Table 120. Amneal Pharmaceuticals Recent Development Table 121. Actavis Elizabeth Company Information Table 122. Actavis Elizabeth Business Overview Table 123. Actavis Elizabeth Etodolac Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 124. Actavis Elizabeth Etodolac Product Portfolio Table 125. Actavis Elizabeth Recent Development Table 126. North America Etodolac Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 127. North America Etodolac Sales by Country (2021-2026) & (k pcs) Table 128. North America Etodolac Sales Market Share by Country (2021-2026) Table 129. North America Etodolac Sales Forecast by Country (2027-2032) & (k pcs) Table 130. North America Etodolac Sales Market Share Forecast by Country (2027-2032) Table 131. North America Etodolac Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. North America Etodolac Market Size by Country (2021-2026) & (US$ Million) Table 133. North America Etodolac Market Share by Country (2021-2026) Table 134. North America Etodolac Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. North America Etodolac Market Share Forecast by Country (2027-2032) Table 136. Europe Etodolac Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 137. Europe Etodolac Sales by Country (2021-2026) & (k pcs) Table 138. Europe Etodolac Sales Market Share by Country (2021-2026) Table 139. Europe Etodolac Sales Forecast by Country (2027-2032) & (k pcs) Table 140. Europe Etodolac Sales Market Share Forecast by Country (2027-2032) Table 141. Europe Etodolac Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Europe Etodolac Market Size by Country (2021-2026) & (US$ Million) Table 143. Europe Etodolac Market Share by Country (2021-2026) Table 144. Europe Etodolac Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Europe Etodolac Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Etodolac Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Etodolac Sales by Country (2021-2026) & (k pcs) Table 148. Asia-Pacific Etodolac Sales Market Share by Country (2021-2026) Table 149. Asia-Pacific Etodolac Sales Forecast by Country (2027-2032) & (k pcs) Table 150. Asia-Pacific Etodolac Sales Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Etodolac Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Etodolac Market Size by Country (2021-2026) & (US$ Million) Table 153. Asia-Pacific Etodolac Market Share by Country (2021-2026) Table 154. Asia-Pacific Etodolac Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Asia-Pacific Etodolac Market Share Forecast by Country (2027-2032) Table 156. Latin America Etodolac Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 157. Latin America Etodolac Sales by Country (2021-2026) & (k pcs) Table 158. Latin America Etodolac Sales Market Share by Country (2021-2026) Table 159. Latin America Etodolac Sales Forecast by Country (2027-2032) & (k pcs) Table 160. Latin America Etodolac Sales Market Share Forecast by Country (2027-2032) Table 161. Latin America Etodolac Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Latin America Etodolac Market Size by Country (2021-2026) & (US$ Million) Table 163. Latin America Etodolac Market Share by Country (2021-2026) Table 164. Latin America Etodolac Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Latin America Etodolac Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Etodolac Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Etodolac Sales by Country (2021-2026) & (k pcs) Table 168. Middle East and Africa Etodolac Sales Market Share by Country (2021-2026) Table 169. Middle East and Africa Etodolac Sales Forecast by Country (2027-2032) & (k pcs) Table 170. Middle East and Africa Etodolac Sales Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Etodolac Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Etodolac Market Size by Country (2021-2026) & (US$ Million) Table 173. Middle East and Africa Etodolac Market Share by Country (2021-2026) Table 174. Middle East and Africa Etodolac Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Middle East and Africa Etodolac Market Share Forecast by Country (2027-2032) Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Etodolac Distributors List Table 179. Etodolac Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Etodolac Image Figure 2. Global Etodolac Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Etodolac Market Size (2021-2032) & (US$ Million) Figure 4. Global Etodolac Sales (2021-2032) & (k pcs) Figure 5. Tablets Image Figure 6. Global Tablets Sales YoY Growth (2021-2032) & (k pcs) Figure 7. Capsules Image Figure 8. Global Capsules Sales YoY Growth (2021-2032) & (k pcs) Figure 9. Global Etodolac Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Etodolac Market Share by Type 2025 VS 2032 Figure 11. North America Etodolac Sales Market Share in Volume by Type in 2025 Figure 12. North America Etodolac Sales Market Share in Value by Type in 2025 Figure 13. Europe Etodolac Sales Market Share in Volume by Type in 2025 Figure 14. Europe Etodolac Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Etodolac Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Etodolac Sales Market Share in Value by Type in 2025 Figure 17. Latin America Etodolac Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Etodolac Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Etodolac Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Etodolac Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Etodolac Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Mild to Moderate Pain Image Figure 24. Global Mild to Moderate Pain Sales YoY Growth (2021-2032) & (k pcs) Figure 25. Rheumatoid Arthritis Image Figure 26. Global Rheumatoid Arthritis Sales YoY Growth (2021-2032) & (k pcs) Figure 27. Osteoarthritis Image Figure 28. Global Osteoarthritis Sales YoY Growth (2021-2032) & (k pcs) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (k pcs) Figure 31. Global Etodolac Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Etodolac Market Share by Application 2025 VS 2032 Figure 33. North America Etodolac Sales Market Share in Volume by Application in 2025 Figure 34. North America Etodolac Sales Market Share in Value by Application in 2025 Figure 35. Europe Etodolac Sales Market Share in Volume by Application in 2025 Figure 36. Europe Etodolac Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Etodolac Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Etodolac Sales Market Share in Value by Application in 2025 Figure 39. Latin America Etodolac Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Etodolac Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Etodolac Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Etodolac Sales Market Share in Value by Application in 2025 Figure 43. North America Etodolac Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 44. North America Etodolac Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Etodolac Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Etodolac Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Etodolac Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 48. Europe Etodolac Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Etodolac Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Etodolac Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Etodolac Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 52. Asia-Pacific Etodolac Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Etodolac Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Etodolac Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Etodolac Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 56. Latin America Etodolac Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Etodolac Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Etodolac Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Etodolac Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 60. Middle East and Africa Etodolac Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Etodolac Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Etodolac Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Etodolac Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Etodolac Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Capsules
Applications
  • Mild to Moderate Pain
  • Rheumatoid Arthritis
  • Osteoarthritis
  • Others
Companies covered
  • Teva
  • Taro Pharmaceuticals
  • Physicians Total Care
  • PD-Rx Pharmaceuticals
  • Nucare Pharmaceuticals
  • Genpharm Ulc
  • Eon Labs
  • Blenheim Pharmacal
  • Apotex
  • Amneal Pharmaceuticals
  • Actavis Elizabeth

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Etodolac Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Etodolac Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Etodolac Market by Type
  6. 1.3.1 Tablets
  7. 1.3.2 Capsules
  8. 1.4 Global Etodolac Market Size by Type
  9. 1.4.1 Global Etodolac Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Etodolac Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Etodolac Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Etodolac Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Etodolac Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Etodolac Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Etodolac Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Etodolac Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Etodolac Industry Trends
  2. 2.2 Etodolac Industry Drivers
  3. 2.3 Etodolac Industry Opportunities and Challenges
  4. 2.4 Etodolac Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Etodolac Revenue (2021-2026)
  2. 3.2 Global Top Players by Etodolac Sales (2021-2026)
  3. 3.3 Global Top Players by Etodolac Price (2021-2026)
  4. 3.4 Global Etodolac Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Etodolac Major Company Production Sites & Headquarters
  6. 3.6 Global Etodolac Company, Product Type & Application
  7. 3.7 Global Etodolac Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Etodolac Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Etodolac Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Etodolac Tier 1, Tier 2, and Tier 3
4 Etodolac Regional Status and Outlook
  1. 4.1 Global Etodolac Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Etodolac Historic Market Size by Region
  3. 4.2.1 Global Etodolac Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Etodolac Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Etodolac Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Etodolac Forecasted Market Size by Region
  7. 4.3.1 Global Etodolac Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Etodolac Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Etodolac Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Etodolac by Application
  1. 5.1 Etodolac Market by Application
  2. 5.1.1 Mild to Moderate Pain
  3. 5.1.2 Rheumatoid Arthritis
  4. 5.1.3 Osteoarthritis
  5. 5.1.4 Others
  6. 5.2 Global Etodolac Market Size by Application
  7. 5.2.1 Global Etodolac Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Etodolac Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Etodolac Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Etodolac Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Etodolac Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Etodolac Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Etodolac Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Etodolac Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Etodolac Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Etodolac Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Taro Pharmaceuticals
  8. 6.2.1 Taro Pharmaceuticals Company Information
  9. 6.2.2 Taro Pharmaceuticals Business Overview
  10. 6.2.3 Taro Pharmaceuticals Etodolac Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Taro Pharmaceuticals Etodolac Product Portfolio
  12. 6.2.5 Taro Pharmaceuticals Recent Developments
  13. 6.3 Physicians Total Care
  14. 6.3.1 Physicians Total Care Company Information
  15. 6.3.2 Physicians Total Care Business Overview
  16. 6.3.3 Physicians Total Care Etodolac Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Physicians Total Care Etodolac Product Portfolio
  18. 6.3.5 Physicians Total Care Recent Developments
  19. 6.4 PD-Rx Pharmaceuticals
  20. 6.4.1 PD-Rx Pharmaceuticals Company Information
  21. 6.4.2 PD-Rx Pharmaceuticals Business Overview
  22. 6.4.3 PD-Rx Pharmaceuticals Etodolac Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 PD-Rx Pharmaceuticals Etodolac Product Portfolio
  24. 6.4.5 PD-Rx Pharmaceuticals Recent Developments
  25. 6.5 Nucare Pharmaceuticals
  26. 6.5.1 Nucare Pharmaceuticals Company Information
  27. 6.5.2 Nucare Pharmaceuticals Business Overview
  28. 6.5.3 Nucare Pharmaceuticals Etodolac Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Nucare Pharmaceuticals Etodolac Product Portfolio
  30. 6.5.5 Nucare Pharmaceuticals Recent Developments
  31. 6.6 Genpharm Ulc
  32. 6.6.1 Genpharm Ulc Company Information
  33. 6.6.2 Genpharm Ulc Business Overview
  34. 6.6.3 Genpharm Ulc Etodolac Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Genpharm Ulc Etodolac Product Portfolio
  36. 6.6.5 Genpharm Ulc Recent Developments
  37. 6.7 Eon Labs
  38. 6.7.1 Eon Labs Company Information
  39. 6.7.2 Eon Labs Business Overview
  40. 6.7.3 Eon Labs Etodolac Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Eon Labs Etodolac Product Portfolio
  42. 6.7.5 Eon Labs Recent Developments
  43. 6.8 Blenheim Pharmacal
  44. 6.8.1 Blenheim Pharmacal Company Information
  45. 6.8.2 Blenheim Pharmacal Business Overview
  46. 6.8.3 Blenheim Pharmacal Etodolac Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Blenheim Pharmacal Etodolac Product Portfolio
  48. 6.8.5 Blenheim Pharmacal Recent Developments
  49. 6.9 Apotex
  50. 6.9.1 Apotex Company Information
  51. 6.9.2 Apotex Business Overview
  52. 6.9.3 Apotex Etodolac Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Apotex Etodolac Product Portfolio
  54. 6.9.5 Apotex Recent Developments
  55. 6.10 Amneal Pharmaceuticals
  56. 6.10.1 Amneal Pharmaceuticals Company Information
  57. 6.10.2 Amneal Pharmaceuticals Business Overview
  58. 6.10.3 Amneal Pharmaceuticals Etodolac Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Amneal Pharmaceuticals Etodolac Product Portfolio
  60. 6.10.5 Amneal Pharmaceuticals Recent Developments
  61. 6.11 Actavis Elizabeth
  62. 6.11.1 Actavis Elizabeth Company Information
  63. 6.11.2 Actavis Elizabeth Business Overview
  64. 6.11.3 Actavis Elizabeth Etodolac Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Actavis Elizabeth Etodolac Product Portfolio
  66. 6.11.5 Actavis Elizabeth Recent Developments
7 North America by Country
  1. 7.1 North America Etodolac Sales by Country
  2. 7.1.1 North America Etodolac Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Etodolac Sales by Country (2021-2026)
  4. 7.1.3 North America Etodolac Sales Forecast by Country (2027-2032)
  5. 7.2 North America Etodolac Market Size by Country
  6. 7.2.1 North America Etodolac Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Etodolac Market Size by Country (2021-2026)
  8. 7.2.3 North America Etodolac Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Etodolac Sales by Country
  2. 8.1.1 Europe Etodolac Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Etodolac Sales by Country (2021-2026)
  4. 8.1.3 Europe Etodolac Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Etodolac Market Size by Country
  6. 8.2.1 Europe Etodolac Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Etodolac Market Size by Country (2021-2026)
  8. 8.2.3 Europe Etodolac Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Etodolac Sales by Country
  2. 9.1.1 Asia-Pacific Etodolac Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Etodolac Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Etodolac Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Etodolac Market Size by Country
  6. 9.2.1 Asia-Pacific Etodolac Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Etodolac Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Etodolac Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Etodolac Sales by Country
  2. 10.1.1 South America Etodolac Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Etodolac Sales by Country (2021-2026)
  4. 10.1.3 South America Etodolac Sales Forecast by Country (2027-2032)
  5. 10.2 South America Etodolac Market Size by Country
  6. 10.2.1 South America Etodolac Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Etodolac Market Size by Country (2021-2026)
  8. 10.2.3 South America Etodolac Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Etodolac Sales by Country
  2. 11.1.1 Middle East and Africa Etodolac Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Etodolac Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Etodolac Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Etodolac Market Size by Country
  6. 11.2.1 Middle East and Africa Etodolac Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Etodolac Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Etodolac Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Etodolac Value Chain Analysis
  2. 12.1.1 Etodolac Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Etodolac Production Mode & Process
  7. 12.2 Etodolac Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Etodolac Distributors
  10. 12.2.3 Etodolac Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst